---
title: "VYNE Therapeutics (VYNE.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/VYNE.US/norm.md"
symbol: "VYNE.US"
name: "VYNE Therapeutics"
parent: "https://longbridge.com/zh-HK/quote/VYNE.US.md"
datetime: "2026-05-21T21:45:52.587Z"
locales:
  - [en](https://longbridge.com/en/quote/VYNE.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/VYNE.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/VYNE.US/norm.md)
---

# VYNE Therapeutics (VYNE.US) — 財務報表

## 損益表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.0838 | -0.1129 | -0.1701 | -0.1346 | -0.2018 |
| ROE | -54.73% | -66.30% | -83.71% | -55.38% | -71.53% |
| 營業收入 | 86000.00 | 130000.00 | 169000.00 | 69000.00 | 202000.00 |
| 凈利潤 | -3.58M | -4.84M | -7.28M | -5.75M | -8.61M |
| 營業利潤 | -3.82M | -5.22M | -7.79M | -7.54M | -9.20M |
| 毛利率 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| 凈利率 | -4168.60% | -3720.77% | -4307.69% | -8340.58% | -4262.87% |
| 利潤含金量 | - | - | - | - | - |

## 資產負債表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 資產與負債 | 25.87M | 30.16M | 36.13M | 44.72M | 56.42M |
| 權益乘數 | 1.05 | 1.09 | 1.13 | 1.15 | 1.28 |
| 每股凈資產 | 0.7387 | 0.8332 | 1.01 | 1.97 | 2.77 |
| 資產周轉率 | 0.0110 | 0.0117 | 0.0093 | 0.0072 | 0.0082 |
| 現金及短投 | 24.93M | 29.01M | 32.70M | 39.65M | 50.27M |
| 存貨與應收 | - | - | - | - | - |
| 長期投資 | 84000.00 | 90000.00 | 96000.00 | 134000.00 | 169000.00 |
| 凈債務 | -24.93M | -29.01M | -32.70M | -39.62M | -50.21M |

## 現金流量表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 經營現金流 | -4.08M | -3.76M | -7.10M | -10.80M | -11.46M |
| 投資現金流 | 4.70M | 8.46M | 4.40M | 4.67M | 19.83M |
| 融資現金流 | -15000.00 | -15000.00 | -7000.00 | -34000.00 | -87000.00 |
| 自由現金流 | -3.40M | -2.19M | -4.63M | -10.65M | -9.19M |
| 現金流充裕率 | - | - | - | - | - |
| 舉債與償債 | - | - | - | - | - |
| 資本支出 | - | - | - | - | - |